featured
Efficacy and Safety of Upadacitinib vs Dupilumab in Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
JAMA Dermatol 2021 Aug 04;[EPub Ahead of Print], A Blauvelt, HD Teixeira, EL Simpson, A Costanzo, M De Bruin-Weller, S Barbarot, VH Prajapati, P Lio, X Hu, T Wu, J Liu, B Ladizinski, AD Chu, K EyerichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.